Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1370 of 5804
-
Could MDMA help new moms battling PTSD and opioid addiction?
Disease control Recruiting nowThis is an open-label study of the use of MDMA Assisted Therapy for postpartum people with co-occurring Post Traumatic Stress Disorder (PTSD) and Opioid Use Disorder (OUD). The study protocol has been adapted from the Phase 3 studies sponsored by the Multidisciplinary Association…
Phase: PHASE2 • Sponsor: University of New Mexico • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New eye injection shows promise for restoring sight after stroke in the eye
Disease control CompletedCentral retinal artery occlusion (CRAO) is an ophthalmologic emergency which leads to severe and permanent vision loss. There is no evidence-based therapy for CRAO. The objective of this GION study is to evaluate the efficacy and safety of KUS121 intravitreal (IVT) injection in p…
Phase: PHASE2 • Sponsor: Kyoto Drug Discovery and Development Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Could a good laugh boost mental health in the elderly?
Symptom relief CompletedThis study was designed and conducted as a randomized controlled experimental research with a pre-test and post-test control group to evaluate the effect of laughter therapy on psychological well-being, life satisfaction, and mental health of elderly individuals living in a nursi…
Phase: NA • Sponsor: Istanbul University - Cerrahpasa • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New drug siplizumab tested in ALS patients – early trial begins
Disease control TerminatedThe purpose of this study is to investigate the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of TCD601 (siplizumab) in newly diagnosed adult ALS patients.
Phase: PHASE1 • Sponsor: ITB-Med LLC • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Radioactive microspheres aimed at prostate cancer: early safety trial underway
Disease control OngoingThe VOYAGER Study is an interventional, non-randomized, single-arm, dose escalation trial with the goal of determining the safety of TheraSphere PCa device in patients with clinically localized prostate cancer across US-based centers.
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Can training teachers and parents curb violence against kids? new study tests it.
Prevention CompletedMore than 1.7 billion children worldwide experience violence in their upbringing. Prevalence rates are particularly high in Africa. Toxic stress associated with violence impacts the developing brain. This affects behavioral, social, and emotional functioning of children. The pres…
Phase: NA • Sponsor: Bielefeld University • Aim: Prevention
Last updated Jun 26, 2026 19:10 UTC
-
Poop pills? fecal transplant trial aims to calm IBS stomachs
Symptom relief Recruiting nowThe purpose of this study is to learn the efficacy and safety of fecal microbiota transplantation (FMT) using stool from a donor with low proteolytic activity and containing the bacteria Alistipes putredinis in patients with irritable bowel syndrome (IBS) and high proteolytic act…
Phase: PHASE2 • Sponsor: Madhusudan (Madhu) Grover, MBBS • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Can a month of pills boost radiation for prostate cancer?
Disease control Recruiting nowThe goal of this clinical trial is to measure the toxicity and effectiveness of the following treatments for cFIR/cgUIR prostate cancer patients. Stereotactic body radiotherapy (SBRT) alone or Stereotactic body radiotherapy (SBRT) combined with Ultrashort GNRH Antagonist called …
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Could stroke patients on blood thinners finally get clot-busting treatment?
Disease control Recruiting nowDirect oral anticoagulants (DOAC) have emerged as safe and efficacious ischemic stroke prophylaxis for non-valvular atrial fibrillation (NVAF). All four DOACs - apixaban, dabigatran, edoxaban, rivaroxaban - were associated with lower risks of major bleeding compared to warfarin. …
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New drug MGC018 tested in tough lung cancer
Disease control OngoingThe goal of this clinical trial is to test MGC018 in patients with relapsed or refractory Extensive-Stage Small-Cell Lung Cancer (ES-SCLC). The main question it aims to answer is: • Does the administration of MGC018 achieve a clinically meaningful response rate of 25% in patient…
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Stomach cancer hope: new combo targets tumors after PD-1 failure
Disease control Recruiting nowTo explore the efficacy and safety of fruquintinib and albumin-paclitaxel combined with or without PD-1 antibody in the second-line treatment of advanced gastric/gastroesophageal junction adenocarcinoma that failed to be treated by anti-PD-1 /PD-L1 regimen
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Silent brain clues: new study hunts for early warning signs of multiple sclerosis
Knowledge-focused CompletedRadiologically isolated syndrome (RIS) often precedes Multiple Sclerosis (MS) but some patients have no symptoms. This study aims to use biological samples and magnetic resonance imaging (MRI) data from four large cohorts of patients with MS in the United States, Europe and Franc…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Can immune cells help islet transplants work better for diabetes?
Disease control ENROLLING_BY_INVITATIONThe goal of this clinical trial is to learn if patients who have brittle type 1 diabetes receiving an islet transplantation will have better control of their sugars if they also receive one of 2 types of immune cells along with the islet transplant. The participants will receive …
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Can a nerve pacemaker that takes breaks still tame an overactive bladder?
Symptom relief CompletedThis will be a prospective, randomized-controlled multi-site trial comparing cyclic versus continuous sacral neuromodulation (SNM) for OAB.
Phase: NA • Sponsor: University Hospitals Cleveland Medical Center • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
New hope for breast cancer recurrence: repeat radiation may spare the breast
Disease control Recruiting nowThis study evaluates the acute toxicity and feasibility of repeat breast conserving therapy with preoperative accelerated partial breast re-irradiation (PAPBI) in female patients aged 51 years or older with ipsilateral recurrent or second primary low-risk breast cancer or DCIS.
Phase: NA • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control OngoingThe study, led by Zhejiang Cancer Hospital and sponsored by Bio-Thera Solutions, Ltd., is an exploratory multicenter, open-label phase Ib-II clinical trial evaluating the safety, tolerability, pharmacokinetic characteristics, and preliminary efficacy of the combination of BAT8008…
Phase: PHASE1, PHASE2 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Can a sleep app ease chronic pain? new trial investigates
Symptom relief OngoingChronic pain constitutes an increasing health and social burden. More than 50% of patients with chronic pain report insomnia, and patients with comorbid insomnia often report stronger and widespread pain, compared to those who are sleeping well. Sleep disturbances are often consi…
Phase: NA • Sponsor: Odense University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
New group therapy aims to heal earthquake grief
Symptom relief OngoingThis study evaluates the effectiveness of an Integrated Grief Therapy (IGT) group program for adults affected by the February 6, 2023 earthquake in Türkiye. Many earthquake survivors experience psychological difficulties such as traumatic stress, grief, and reduced resilience aft…
Phase: NA • Sponsor: Sakarya University • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
New targeted drug shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis is a first-in-human, dose finding and dose expansion study to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary antitumor activity of BG-C9074 alone and in combination with other anticancer therapies in patients with advanced solid t…
Phase: PHASE1 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New heart drug EDG-7500 enters Mid-Stage trial for thick heart muscle
Disease control OngoingThis study is being conducted in order to understand the safety and effects of different doses of EDG-7500 as a single dose in adults with obstructive hypertrophic cardiomyopathy (oHCM) and as multiple doses in adults with obstructive or nonobstructive hypertrophic cardiomyopathy…
Phase: PHASE2 • Sponsor: Edgewise Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC